Key Insights

Highlights

Success Rate

71% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 72/100

Termination Rate

20.0%

2 terminated out of 10 trials

Success Rate

71.4%

-15.1% vs benchmark

Late-Stage Pipeline

10%

1 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed with results

Key Signals

1 with results71% success

Data Visualizations

Phase Distribution

10Total
Not Applicable (8)
Early P 1 (1)
P 4 (1)

Trial Status

Completed5
Terminated2
Active Not Recruiting1
Enrolling By Invitation1
Recruiting1

Trial Success Rate

71.4%

Benchmark: 86.5%

Based on 5 completed trials

Clinical Trials (10)

Research Network

Activity Timeline